Chun‐Yan Wang
Research Subjects
Chun‐Yan Wang has a total of 112 co-authors. Here are the top co-authors by number of shared publications:
- Dong Ji
Senior Department of Hepatology Chinese PLA General Hospital Beijing China
4 shared publications - Ya Deng
The Second School of Clinical Medicine,Southern Medical University,Guangzhou,China
3 shared publications Jing Xu
Department of Liver Disease, the Second People's Hospital of Fuyang City, Fuyang, 236015, Anhui, China
2 shared publicationsAdriana Cabrales
For the Personalizing Outcomes After Child Cardiac Arrest (POCCA) Investigators
1 shared publication- Alexis A. Topjian
Department of Anesthesiology and Critical Care Medicine, Children’s Hospital of Philadelphia, University of Pennsylvania Perelman School of Medicine, Philadelphia, PA
1 shared publication - Aline B. Maddux
Departments of Pediatrics, Section of Critical Care Medicine University of Colorado School of Medicine and Children's Hospital Colorado Aurora Colorado USA
1 shared publication
Latest Publications
- 17 December 2025
- Published by Elsevier in Antiviral Research
- Vol. 246, 106334
Low-level viremia increases the risk of adverse long-term outcomes in entecavir-treated patients with chronic hepatitis B
- 17 December 2025
- Published by Elsevier in Antiviral Research
- Vol. 246, 106334
Low-level viremia increases the risk of adverse long-term outcomes in entecavir-treated patients with chronic hepatitis B
- Open Access
- 8 September 2022
- Published by American Medical Association (AMA) in JAMA Network Open
- Vol. 5 (9) , e2230518
Association of Blood-Based Brain Injury Biomarker Concentrations With Outcomes After Pediatric Cardiac Arrest
Approximately 10 000 children experience in-hospital or out-of-hospital cardiac arrest annually in the US.1,2 Children with return of spontaneous circulation (ROSC) are at high risk of neurological morbidity and death due to global hypoxic-ischemic brain injury.3 Accurate early understanding of the risk of neurological injury could support clinician and family decision-making and treatment. However, a standardized validated approach is lacking.4
- 8 September 2022
- Published by American Medical Association (AMA) in JAMA Network Open
- Vol. 5 (9) , e2230518
Open AccessAssociation of Blood-Based Brain Injury Biomarker Concentrations With Outcomes After Pediatric Cardiac Arrest
Approximately 10 000 children experience in-hospital or out-of-hospital cardiac arrest annually in the US.1,2 Children with return of spontaneous circulation (ROSC) are at high risk of neurological morbidity and death due to global hypoxic-ischemic brain injury.3 Accurate early understanding of the risk of neurological injury could support clinician and family decision-making and treatment. However, a standardized validated approach is lacking.4
- 3 February 2022
- Published by Wolters Kluwer Health in Hepatology
- Vol. 76 (1) , E15
Reply
- Open Access
- 31 January 2022
- Published by Wolters Kluwer Health in Hepatology
- Vol. 75 (5) , 1349-1351
Reply
- 31 January 2022
- Published by Wolters Kluwer Health in Hepatology
- Vol. 75 (5) , 1349-1351
Open AccessReply
- 16 December 2021
- Published by Wolters Kluwer Health in Hepatology
- Vol. 75 (6) , 1373-1385
Prediction of biochemical nonresolution in patients with chronic drug‐induced liver injury: A large multicenter study
Background and Aims: To clarify high‐risk factors and develop a nomogram model to predict biochemical resolution or biochemical nonresolution (BNR) in patients with chronic DILI. Approach and Results: Retrospectively, 3655 of 5326 patients with chronic DILI were enrolled from nine participating hospitals, of whom 2866 underwent liver biopsy. All of these patients were followed up for over 1 year and their clinical characteristics were retrieved from electronic medical records. The endpoint was BNR, defined as alanine aminotransferase or aspartate aminotransferase >1.5× upper limit of normal or alkaline phosphatase >1.1× ULN, at 12 months from chronic DILI diagnosis. The noninvasive high‐risk factors for BNR identified by multivariable logistic regression were used to establish a nomogram, which was validated in an independent external cohort. Finally, 19.3% (707 of 3655) patients presented with BNR. Histologically, with the increase in liver inflammation grades and fibrosis stages, the proportion of BNR significantly increased. The risk of BNR was increased by 21.3‐fold in patients with significant inflammation compared to none or mild inflammation (p < 0.001). Biochemically, aspartate aminotransferase and total bilirubin, platelets, prothrombin time, sex, and age were associated with BNR and incorporated to construct a nomogram model (BNR‐6) with a concordance index of 0.824 (95% CI, 0.798–0.849), which was highly consistent with liver histology. These results were successfully validated both in the internal cohort and external cohort. Conclusions: Significant liver inflammation is a robust predictor associated with biochemical nonresolution. The established BNR‐6 model provides an easy‐to‐use approach to assess the outcome of chronic DILI.
- 16 December 2021
- Published by Wolters Kluwer Health in Hepatology
- Vol. 75 (6) , 1373-1385
Prediction of biochemical nonresolution in patients with chronic drug‐induced liver injury: A large multicenter study
Background and Aims: To clarify high‐risk factors and develop a nomogram model to predict biochemical resolution or biochemical nonresolution (BNR) in patients with chronic DILI. Approach and Results: Retrospectively, 3655 of 5326 patients with chronic DILI were enrolled from nine participating hospitals, of whom 2866 underwent liver biopsy. All of these patients were followed up for over 1 year and their clinical characteristics were retrieved from electronic medical records. The endpoint was BNR, defined as alanine aminotransferase or aspartate aminotransferase >1.5× upper limit of normal or alkaline phosphatase >1.1× ULN, at 12 months from chronic DILI diagnosis. The noninvasive high‐risk factors for BNR identified by multivariable logistic regression were used to establish a nomogram, which was validated in an independent external cohort. Finally, 19.3% (707 of 3655) patients presented with BNR. Histologically, with the increase in liver inflammation grades and fibrosis stages, the proportion of BNR significantly increased. The risk of BNR was increased by 21.3‐fold in patients with significant inflammation compared to none or mild inflammation (p < 0.001). Biochemically, aspartate aminotransferase and total bilirubin, platelets, prothrombin time, sex, and age were associated with BNR and incorporated to construct a nomogram model (BNR‐6) with a concordance index of 0.824 (95% CI, 0.798–0.849), which was highly consistent with liver histology. These results were successfully validated both in the internal cohort and external cohort. Conclusions: Significant liver inflammation is a robust predictor associated with biochemical nonresolution. The established BNR‐6 model provides an easy‐to‐use approach to assess the outcome of chronic DILI.